Otsuka Chemical (India) Private Limited was incorporated in 2006 with an object to produce Advance Cephalosporin Drug Intermediate namely “GCLE”. Since Indian Pharmaceutical Industry is the largest consumer of GCLE across the world, and we wanted to be close to the customers, Otsuka decided to set up GCLE manufacturing facility in India.

With the above aim, the company set up a fully automatic DCS controlled plant at Kotputli, in Rajasthan, India. The plant has come into full operations since May 2008.

GCLE is a major raw material to produce some vital Cephalopodan antibiotics such as, Cefixime, Cefdinir, Cefprozil and Cefpodoxime, We are well supported by world class research facilities and having world class manufacturing facility in India. Our focus is to provide the best services to our customers, vendors and associate partners. OCIL is committed to energy conservation, environment and water resources.